Dr. Erin Murphy talks about a study presented by Dr. Thomas E. Merchant regarding young patients with ependymoma and how they can be treated effectively with a regiment of adjuvant radiation.
Erin Murphy, MD, Radiation Oncologist at Cleveland Clinic, talks about a study presented by Thomas E. Merchant, DO, PhD, Chair, Radiation Oncology Department at St. Jude Children’s Research regarding young patients with ependymoma and how they can be treated effectively with a regiment of adjuvant radiation.
Murphy says that some patients who undergo a subtotal resection for ependymoma can go on to receive chemotherapy and possibly be eligible for a gross total resection.
Real-World Data Supports Avelumab Use for Locally Advanced, Metastatic Urothelial Carcinoma
February 20th 2023Treatment with avelumab for locally advanced or metastatic urothelial carcinoma showed to be consistent in a real-world with what was previously seen in the phase 3 JAVELIN Bladder 100 trial.
Read More
Vedolizumab and Standard Prophylaxis Proves Effective in Preventing GI aGVHD
February 19th 2023The phase 3 GRAPHITE study showed that vedolizumab plus standard prophylaxis after unrelated allogeneic hematopoietic stem cell transplantation was more effective vs placebo for the prevention of lower gastrointestinal graft-vs-host disease.
Read More
Iomab-B Shows Significant Improvement in R/R AML Over Chemotherapy Prior to Allogeneic HCT
February 19th 2023In findings from the phase 3 SIERRA trial, Iomab-B-based conditioning for patients with relapsed or refractory acute myeloid leukemia provided significant efficacy and tolerable safety results over the current standard of care.
Read More
2 Clarke Drive
Cranbury, NJ 08512